Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer. It can be used to study hypertension, Alzheimer's disease and arteriosclerosis.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 75,500 |
5 mg | 在庫あり | ¥ 183,500 |
10 mg | 在庫あり | ¥ 250,500 |
25 mg | 在庫あり | ¥ 379,000 |
50 mg | 在庫あり | ¥ 512,000 |
100 mg | 在庫あり | ¥ 672,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 206,000 |
説明 | CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer. It can be used to study hypertension, Alzheimer's disease and arteriosclerosis. |
分子量 | 339.37 |
分子式 | C17H13N3O3S |
CAS No. | 681173-76-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.39 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CID-5056270 681173-76-2 Cell Cycle/Checkpoint Cytoskeletal Signaling Stem Cells ROCK CID 5056270 CID5056270 Inhibitor inhibitor inhibit